Gloria A. Breault - Concepedia

Concepedia

Author

Gloria A. Breault

AstraZeneca (United Kingdom)

Also Known As

Breault, Gloria A., G. A. BREAULT, G. BREAULT, G. Breault, G.A. Breault, Gloria A Breault, Gloria A. Breault, Gloria Breault

22

Publications

1.2K

Citations

14

H-Index

38

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)University of Sheffield Brown University

GA

About

Gloria A. Breault is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	473
2	Natural Sciences	6	6	555
3	Biochemistry	4	4	295
4	Engineering	2	2	111
5	Health Sciences	1	1	59

Gloria A. Breault

×

14

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Supramolecular topology Gloria A. Breault, Christopher A. Hunter, Paul C. Mayers Tetrahedron	1999	272
Synthesis of a molecular trefoil knot by folding and closing on an octahedral coordination template Jun Guo, Paul C. Mayers, Gloria A. Breault, Nature Chemistry Supramolecular AssemblyNatural SciencesMolecular Trefoil KnotMolecular BiologyOrganometallic Catalysis	2010	167
Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation Malcolm Anderson, John F. Beattie, Gloria A. Breault, Bioorganic & Medicinal Chemistry Letters Cyclin-dependent Kinase InhibitorsMedicinal ChemistryBioorganic ChemistryHeterocyclicBiochemistry	2003	114
Knot tied around an octahedral metal centre Harry Adams, Eleanor Ashworth, Gloria A. Breault, Nature LabyrinthOctahedral Metal CentreKnot Theory	2001	113
Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity Folkert Reck, Richard A. Alm, Patrick Brassil, Journal of Medicinal Chemistry Reduced Herg ActivityAntimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceMedicinal Chemistry	2011	101
Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimisation of substituted 4,6-Bis anilino pyrimidines John F. Beattie, Gloria A. Breault, Rebecca Ellston, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryCyclin-dependent Kinase 4MedicineNatural SciencesRational Drug Design	2003	88
The temporary silicon connection in the control of the regiochemistry of 4 + 2 cycloadditions Gilbert Stork, Tin Yau Chan, Gloria A. Breault Journal of the American Chemical Society EngineeringAltmetric Attention ScoreBibliometricsOrganic ChemistryChemistry	1992	73
Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines Gloria A. Breault, Rebecca Ellston, Stephen Green, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryCyclin-dependent Kinase 4MedicineNatural SciencesRational Drug Design	2003	64
Influence of Solvent on Aromatic Interactions in Metal Tris-Bipyridine Complexes Gloria A. Breault, Christopher A. Hunter, Paul C. Mayers Journal of the American Chemical Society	1998	59
Antibacterial FabH Inhibitors with Mode of Action Validated in <i>Haemophilus influenzae</i> by in Vitro Resistance Mutation Mapping David C. McKinney, Charles J. Eyermann, Rong-Fang Gu, ACS Infectious Diseases Action ValidatedEscherichia ColiAntimicrobial ChemotherapyAntibiotic ResistanceBacterial Pathogens	2016	59

Page 1